title: Antiparasitic Effect of Vitamin B12 on Trypanosoma cruzi.
abstract: A nutritional characteristic of trypanosomatid protozoa is that they need a heme compound as a growth factor. Because of the cytotoxic activity of heme and its structural similarity to cobalamins, we have investigated the in vitro and in vivo effect of vitamin B(12) (or cyanocobalamin) on the different forms of Trypanosoma cruzi. Cyanocobalamin showed a marked antiparasitic activity against epimastigotes (50% inhibitory concentration [IC(50)], 2.42 μM), amastigotes (IC(50), 10.69 μM), and trypomastigotes (IC(50), 9.46 μM). Anti-epimastigote and -trypomastigote values were 1.7 to 4 times lower than those obtained with the reference drug benznidazole (Bnz). We also found that B(12) and hemin do not interact with each other in their modes of action. Our results show that B(12) increases intracellular oxidative activity and stimulates both superoxide dismutase (50%) and ascorbate peroxidase (20%) activities, while the activity of trypanothione reductase was not modified. In addition, we found that the antioxidants dithiothreitol and ascorbic acid increase the susceptibility of the parasite to the cytotoxic action of B(12). We propose that vitamin B(12) exerts its growth-inhibitory effect through the generation of reactive oxygen species. In an in vivo assay, a significant reduction in the number of circulating parasites was found in T. cruzi-infected mice treated with cyanocobalamin and ascorbic acid. The reduction of parasitemia in benznidazole-treated mice was improved by the addition of these vitamins. According to our results, a combination of B(12) and Bnz should be further investigated due to its potential as a new therapeutic modality for the treatment of Chagas' disease.
authors.affiliation: Centro de Investigaciones sobre Porfirinas y Porfirias, CIPYP (UBA-CONICET), Hospital de Clínicas José de San Martín, UBA, Buenos Aires, Argentina.
authors.forename: Alejandra B
authors.initials: AB
authors.lastname: Ciccarelli
authors.forename: Fernanda M
authors.initials: FM
authors.lastname: Frank
authors.forename: Vanesa
authors.initials: V
authors.lastname: Puente
authors.forename: Emilio L
authors.initials: EL
authors.lastname: Malchiodi
authors.forename: Alcira
authors.initials: A
authors.lastname: Batlle
authors.forename: Maria Elisa
authors.initials: ME
authors.lastname: Lombardo
mesh_terms: D000818:Animals; D014355:Chagas Disease / Q000188:drug therapy / Q000469:parasitology; D005260:Female; D008297:Male; D051379:Mice; D009593:Nitroimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D014344:Trypanocidal Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D014349:Trypanosoma cruzi / Q000187:drug effects*; D014805:Vitamin B 12 / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D009593:Nitroimidazoles; D014344:Trypanocidal Agents; D014805:Vitamin B 12; C009999:benzonidazole